Aytu BioScience, Inc. ($AYTU) - buy or sell? Stock discussion, ideas, forum

Aytu BioScience, Inc.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN
$AYTU	Nasdaq	US0547547002

Recent news

Synacor, Inc. reports 33.2% revenue decline in FY2020

BSQUARE Corporation reports 20.5% revenue decline in 2020 and 11.3 pp EBITDA Margin growth from -12.5% to -1.2%

eMagin Corporation CAPEX surged on 125% and Revenue jumped on 10.1%

Viveve Medical, Inc. reports 28.2% CAPEX decline in 2020 and 16.6% Revenue decline

Canadian Solar Inc. Debt jumped on 22.2% and Revenue increased on 8.6%

SMTC Corporation Debt increased on 5.4% while EBITDA decreased on 3.8%

SharpSpring, Inc. revenue growth accelerated from 21.7% in FY2019 to 29.0% in FY2020

Interlink Electronics, Inc. reports 8.1 pp EBITDA Margin growth from -2.3% to 5.9% in 2020 in 2020 while 5.7% Revenue decline

Intellicheck, Inc. Net Income jumped on 122% and Revenue jumped on 40.1%

VirnetX Holding Corp revenue jumped on 355,942% and EBITDA Margin surged on 23,179 pp from -23,127% to 52.2%

Twit about AYTU stock

Share your investment idea or question on Aytu BioScience, Inc. stock:

Latest twits on Aytu BioScience, Inc. (AYTU)

No twits yet. Be the first to post!

Have a question about AYTU? Ask and other investors will be eager to help you.

Have an idea about AYTU? Share it with other investors.

Aytu BioScience, Inc. news

10/06/2020 Aytu BioScience, Inc. CAPEX surged on 945% and Revenue jumped on 277%

Aytu BioScience, Inc. stock price chart

Aytu BioScience, Inc. financials

mln. $	FY2015	FY2016	FY2017

Revenue	0.262	2.562	3.222
EBITDA	-7.514	-20.830	-15.761
Net income	-7.723	-28.180	-22.508
CAPEX	0.000	0.253	6.112
Debt	0.000	0.000	0.000
Cash	7.353	8.054	0.802

Aytu BioScience, Inc. news

10/06/2020 Aytu BioScience, Inc. CAPEX surged on 945% and Revenue jumped on 277%

About Aytu BioScience, Inc.

Aytu BioScience, Inc. operates as a specialty healthcare company. The Company concentrates on acquiring, developing, and commercializing products focused primarily on sexual disfunction disorders, urological cancer, urinary tract infections, and male infertility. Aytu Bioscience serves patients and customers worldwide.